DESCRIPTION:Etodolac is a non-steroidal anti-inflammatory (NSAID) medication that is often used to treat moderate or mild pain, osteoarthritis, and rheumatoid arthritis. Veterinarians also use it to treat other problems and conditions.
Key Benefits: Etodolac works by reducing the hormones within the body that cause inflammation and pain.
Formulated For: For dogs only.
How is Medication Given? Follow your veterinarian's directions when using this product.
What Results Can I Expect? Etodolac treats pain, reduces inflammation, and reduces fevers.
What Form Does Medication Come In? Tablet
Dose and Administration: Sold individually in capsule (300 mg) or tablet (400 mg) form.
Possible Side Effects: Potential adverse reactions include:
Vomiting Diarrhea Inappetence Gastroenteritis Gastrointestinal Bleeding Melena Gastrointestinal Ulcers HypoproteinemiaElevation in Pancreatic Enzymes Abnormal Liver Function Test Results Elevation in Hepatic Enzymes Icterus Acute Hepatitis Anemia Hemolytic Anemia Thrombocytopenia Prolonged Bleeding Duration Ataxia Paresis Aggression Sedation Hyperactivity Disorientation Hyperesthesia Seizures Vestibular Signs KCS (Keratoconjunctivitis Sicca) Polydipsia Polyuria Urinary Incontinence Azotemia Acute Renal Failure Proteinuria Hematuria Pruritus Dermatitis Edema
Precautions:
NSAID use can cause gastrointestinal ulceration or perforation. Therefore, administering Etodolac in conjunction with any other NSAID, corticosteroid, or anti-inflammatory should always be avoided. Carefully approach and monitor concomitant use of potentially nephrotoxic drugs. NSAIDs can inhibit homeostatic function-maintaining prostaglandins, causing severe disease in animals with undiagnosed underlying or pre-existing disease. Adverse reaction sensitivity varies from one patient to the next. Dogs with previous adverse reactions to another NSAID could experience the same reaction with any other NSAID. Those at the highest risk for an adverse reaction are animals with hepatic dysfunction, cardiovascular dysfunction, renal dysfunction, those taking diuretics, or those who are dehydrated. Proper washout times should be considered if you are switching the animal from one NSAID to another or from corticosteroid to NSAID treatment. Cyclooxygenase-inhibiting NSAIDs can cause hepatic, gastrointestinal, and renal toxicity. Safety is not proven for use in puppies under 12 months old, pregnant, breeding, or lactating dogs. Monitoring is important during any surgery, as well as for patients taking any adjunctive therapy (to ensure compatibility). Concomitant drug use and its influence on Etodolac metabolism has never been studied. This includes protein-bound drugs, which are common among behavioral, anticonvulsant, and cardiac drugs. The effects of concomitant use of metabolism-inhibiting medications has not been studied. Routine re-evaluation should take place to determine whether or not Etodolac is still needed and well-tolerated. Discontinue use if your dog shows signs of inappetence, emesis, fecal abnormalities, or anemia. This drug can worsen the clinical signs of dogs with pre-existing occult gastrointestinal abnormalities, hepatic abnormalities, cardiovascular abnormalities, blood dyscrasias, or bleeding disorders. If the animal needs more pain medication in addition to the daily Etodolac dose, an analgesic from a different (non-NSAID) drug class might be required. Pets should be monitored for symptoms of a drug reaction. Keep out of reach of animals and children.
Storage Recommendations: Store in a cool and dry location.
In Case of Overdose: Contact the nearest emergency pet clinicimmediately.
